Ronald Howell joined WRF in 1989 to execute the Foundation’s licensing strategy on Ben Hall’s platform technology expressing heterologous proteins in yeast. After becoming CEO in 1992, he led the […]
Ronald Howell joined WRF in 1989 to execute the Foundation’s licensing strategy on Ben Hall’s platform technology expressing heterologous proteins in yeast. After becoming CEO in 1992, he led the […]